Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Senate Democrats Introduce Bill to Allow Government to Block Drug Price Rises

Reuters Staff  |  December 14, 2018

WASHINGTON (Reuters)—Four Democratic U.S. senators introduced a bill on Thursday that would allow the government to block drug price increases that it decides are unjustified.

The bill sponsored by Senators Richard Blumenthal, Kamala Harris, Amy Klobuchar and Jeff Merkley, all Democrats, would allow the Department of Health and Human Services to prohibit drug price increases that it deems excessive.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Both Republicans and Democrats have put the issue of fast-rising drug prices – some for drugs like insulin that have been on the market for decades – on their agenda.

Representative Nancy Pelosi, who leads Democrats in the House of Representatives, has pledged to pursue an agenda next year that includes tackling the issue of high and rising prescription drug prices.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

U.S. President Donald Trump has blasted drugmakers and healthcare “middlemen” for making prescription medicines unaffordable for Americans.

Share: 

Filed under:Legislation & Advocacy Tagged with:drug price legislationJeff MerkleyKamala Harrisprohibit drug price increasesRichard Blumenthal

Related Articles

    What’s in the New Biden Plan to Reduce U.S. Drug Prices?

    November 4, 2021

    WASHINGTON (Reuters)—U.S. President Joe Biden and his fellow Democrats promised voters sweeping drug price reform in their signature social spending bill but agreed to move ahead with a far less ambitious proposal after facing opposition in Congress. The plan could still fail as hurdles remain to approving the broader spending package, known as “Build Back…

    U.S. Senate Mulls Bare-Bones Healthcare Bill; Marathon of Voting Expected

    July 27, 2017

    WASHINGTON (Reuters)—U.S. Senate Republicans embarked on Thursday on another push to unravel Obamacare, working on a stripped-down bill after failing to pass broader legislation and complete a seven-year campaign to gut a law that extended health coverage to millions. Republicans leaders hope a so-called skinny bill can draw enough votes to pass despite unified Democratic…

    Sen. Sanders, Rep. Cummings to Introduce Bill to Lower U.S. Drug Prices

    January 11, 2019

    WASHINGTON (Reuters)—U.S. Senator Bernie Sanders and Representative Elijah Cummings plan to introduce legislation on Thursday aimed at lowering the cost of prescription drugs for U.S. consumers. Democrats have been critical of efforts by the Trump administration to bring down drug prices after President Donald Trump promised to do so during his campaign and since being…

    State Funding Changes in Spotlight in U.S. Republican Healthcare Bill

    September 22, 2017

    WASHINGTON (Reuters)—Republican leaders sought to nail down the final votes needed to pass what U.S. Vice President Mike Pence on Thursday called their “last best chance” to repeal Obamacare while a new analysis underscored how Democratic-leaning states stand to lose large amounts of federal funding under the legislation. Senate Majority Leader Mitch McConnell (R-Ky.) plans…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences